Please use this identifier to cite or link to this item:
|Title:||Platinum(II) triammine antitumour complexes: Structure-activity relationship with guanosine 5′-monophosphate (5′-GMP)|
|Citation:||Jin, V.X., Tan, S.I., Ranford, J.D. (2005-02-10). Platinum(II) triammine antitumour complexes: Structure-activity relationship with guanosine 5′-monophosphate (5′-GMP). Inorganica Chimica Acta 358 (3) : 677-686. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ica.2004.09.024|
|Abstract:||The multinuclear ( 1H, 15N, 31P and 195Pt) NMR spectroscopies, ES-MS and HPLC have been employed to investigate the structure-activity relationship for the reactions between guanosine 5′-monophosphate (5′-GMP) and the platinum(II)-triamine complexes of the general formulation cis-[Pt(NH 3) 2(Am)Cl] NO 3 (where Am represents a substituted pyridine). The order of reaction rate of the reactions was found to be: 3-phpy > 4-phpy > py > 4-mepy > 3-mepy > 2-mepy. The two basic factors, steric and electronic, were attributed to the order of the binding rate constants. A possible mechanism of the reaction of cis-[Pt(NH 3) 2(Am)Cl] + with 5′-GMP suggested that the reactions proceed via direct nucleophilic attack and no loss of ammonia. cis-[Pt(NH 3) 2(Am)Cl] + binds to the N7 nitrogen of the guanine residue of 5′-GMP to form a coordinate bond with the Pt metal centre. This mechanism is apparently different from that of cisplatin. The pK a value of cis-[Pt(NH 3) 2(4-mepy)(H 2O)](NO 3) 2 (5.63) has been determined at 298 K by the use of distortionless enhancement by polarization transfer (DEPT) 15N NMR spectroscopy and compared to the pK a value of cis-[PtCl(H 2O)(NH 3) 2] +. © 2004 Elsevier B.V. All rights reserved.|
|Source Title:||Inorganica Chimica Acta|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 19, 2018
WEB OF SCIENCETM
checked on Jun 25, 2018
checked on Jun 22, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.